Press Releases and Product Information February 1, 2023
advertisement
- Tidepool lands long-awaited FDA nod for artificial pancreas app connecting CGMs, insulin pumps
- AGC Biologics to Commercial Manufacture Provention Bio Diabetes Therapy
- iTolerance, Inc. Enters into Master Services Agreement with the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine to Advance iTOL-100 Platform Technology for Type 1 Diabetes
- Fewer known risk factors, but heightened risk of cardiovascular disease in people with celiac disease